Subject
Cardiology and Cardiovascular Medicine
Reference15 articles.
1. Gay H, Yu J, Persell SD, et al. Comparison of sodium glucose transporter-2 inhibitor and glucagon like peptide-1 receptor agonist prescribing in patients with diabetes mellitus, with and without cardiovascular disease in integrated health care clinics vs. community primary care practices. Am J Cardiol In press.
2. Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US;Eberly;JAMA Netw Open,2021
3. Association of race and ethnicity with prescription of SGLT2 Inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration System;Lamprea-Montealegre;JAMA,2022
4. National trends in use of sodium-glucose cotransporter-2 Inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020;Adhikari;J Am Heart Assoc,2022
5. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2021;Diabetes Care,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献